Holen Sie sich die Stockscreener-App
0.3426
31.67%
0.0824
Schlusskurs vom Vortag:
$0.2602
Offen:
$0.34957
24-Stunden-Volumen:
22,400
Relative Volume:
0.01
Marktkapitalisierung:
$5.23M
Einnahmen:
$17.21M
Nettoeinkommen (Verlust:
$-23.45M
KGV:
-0.0591
EPS:
-5.7938
Netto-Cashflow:
$-36.90M
1W Leistung:
-48.95%
1M Leistung:
-69.41%
6M Leistung:
-84.14%
1J Leistung:
-85.96%
1-Tages-Spanne:
$0.325
$0.3796
1-Wochen-Bereich:
$0.257
$0.599
52-Wochen-Spanne:
$0.257
$4.18
Allurion Technologies Inc Stock (ALUR) Company Profile
Firmenname
Allurion Technologies Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare ALUR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
0.3502 | 10.03M | 17.21M | -23.45M | -36.90M | -5.7938 |
|
ABT
Abbott Laboratories
|
107.84 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.93 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.46 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.68 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.22 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | Eingeleitet | TD Cowen | Buy |
| 2024-09-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-02-09 | Eingeleitet | Jefferies | Buy |
Allurion Technologies Inc Aktie (ALUR) Neueste Nachrichten
Aug Chart Watch: What are Allurion Technologies Incs recent SEC filings showingPortfolio Update Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Allurion Technologies Appeals NYSE Delisting, Leverages FDA Approval to Regain Listing Compliance and Launch Gastric Balloon System in U.S. 1 - Minichart
Allurion Faces NYSE Delisting, Shifts Trading to OTC - TipRanks
Allurion Technologies Received Notice of Delisting - TradingView
Allurion appeals NYSE delisting, cites FDA approval in compliance plan - Investing.com
Allurion Advances Plan to Regain Listing Compliance - Business Wire
Market Outlook: Is Allurion Technologies Inc Equity Warrant being accumulated by smart money2026 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy - Business Wire
Pretax income of Allurion Technologies Inc. – OTC:ALURW - TradingView
Weight Loss Devices Market Poised for Rapid Expansion to USD - openPR.com
Why did Allurion stock surge over 50% today? - MSN
Death Cross: How Allurion Technologies Inc. stock valuations compare to rivalsWeekly Trade Review & Target Return Focused Stock Picks - Naître et grandir
Intercontinental Exchange : NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - marketscreener.com
GN Store Nord (OTCMKTS:GNNDY) and Allurion Technologies (NYSE:ALUR) Financial Survey - Defense World
CPUHCompute Health Acquisition Corp. Warrant Holders Hold Special Meeting - ADVFN Ltd
8 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
NYSE initiates delisting proceedings against Allurion By Investing.com - Investing.com Canada
RTW funds report 39.4% Allurion (ALUR) ownership in 13D amendment - Stock Titan
Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy - TipRanks
NYSE initiates delisting proceedings against Allurion - Investing.com
Allurion intends to appeal NYSE notice of delisting, execute plan to regain compliance, and expects to continue trading on NYSE - marketscreener.com
ALLURION TECHNOLOGIES announced that the company plans to formally appeal the delisting notice issued by the New York Stock Exchange. - Bitget
NYSE moves to delist Allurion (NYSE: ALUR) as company plans appeal - Stock Titan
Nyse to commence delisting proceedings against Allurion Technologies, Inc. - marketscreener.com
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE - Business Wire
NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc. - TradingView
NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) - FinancialContent
Allurion Technologies (NYSE:ALUR) & CeriBell (NASDAQ:CBLL) Head-To-Head Survey - Defense World
ALUR Should I Buy - Intellectia AI
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance
What's going on with Allurion stock on Wednesday? - MSN
FDA approves Allurion’s gastric balloon system - BioWorld MedTech
Contrasting Allurion Technologies (NYSE:ALUR) and Metastat (OTCMKTS:MTST) - Defense World
What's Going On With Allurion Stock On Wednesday? - Benzinga
Allurion Technologies amends warrant terms and raises $3 million through inducement offer - Investing.com Nigeria
Allurion Technologies Amends Warrants to Bolster Liquidity - TipRanks
Allurion Lowers Warrant Exercise Price to $1.15, Raises ~$3M and Issues 5.32M New Warrants - TradingView
Allurion Technologies (ALUR) secures $3M via warrant repricing and new warrants - Stock Titan
Why Did Allurion Stock Surge Over 50% Today? - Stocktwits
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Chardan Capital Upgrades Allurion Technologies (ALUR) - Nasdaq
Strategic Acquisition Amplifies Allurion’s Market Presence - StocksToTrade
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings - Benzinga
Allurion Technologies upgraded to Buy from Neutral at Chardan - TipRanks
Allurion Technologies stock rating upgraded on FDA approval By Investing.com - Investing.com India
Allurion stock balloons as FDA signs off on weight loss device - Fierce Biotech
ALUR Sees Market Volatility Amidst Strategic Moves and Market Challenges - timothysykes.com
Allurion Technologies stock rating upgraded on FDA approval - Investing.com UK
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Business Wire
Chardan Upgrades Allurion Technologies to Buy From Neutral, $3 Price Target - marketscreener.com
Finanzdaten der Allurion Technologies Inc-Aktie (ALUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):